Toll-Like Receptor (TLR)-7 and -8 Modulatory Activities of Dimeric Imidazoquinolines

Journal of Medicinal Chemistry
2012.0

Abstract

Toll-like receptors (TLRs) are pattern recognition receptors that recognize specific molecular patterns present in molecules that are broadly shared by pathogens but are structurally distinct from host molecules. The TLR7-agonistic imidazoquinolines are of interest as vaccine adjuvants given their ability to induce pronounced Th1-skewed humoral responses. Minor modifications on the imidazoquinoline scaffold result in TLR7-antagonistic compounds which may be of value in addressing innate immune activation-driven immune exhaustion observed in HIV. We describe the syntheses and evaluation of TLR7 and TLR8 modulatory activities of dimeric constructs of imidazoquinoline linked at the C2, C4, C8, and N(1)-aryl positions. Dimers linked at the C4, C8, and N(1)-aryl positions were agonistic at TLR7; only the N(1)-aryl dimer with a 12-carbon linker was dual TLR7/8 agonistic. Dimers linked at C2 position showed antagonistic activities at TLR7 and TLR8; the C2 dimer with a propylene spacer was maximally antagonistic at both TLR7 and TLR8.

Knowledge Graph

Similar Paper

Toll-Like Receptor (TLR)-7 and -8 Modulatory Activities of Dimeric Imidazoquinolines
Journal of Medicinal Chemistry 2012.0
Development, Optimization, and In Vivo Validation of New Imidazopyridine Chemotypes as Dual TLR7/TLR9 Antagonists through Activity-Directed Sequential Incorporation of Relevant Structural Subunits
Journal of Medicinal Chemistry 2022.0
Efficacy of TLR7 agonistic imidazoquinoline as immunochemotherapeutic agent against P. Berghei ANKA infected rodent host
Bioorganic & Medicinal Chemistry Letters 2019.0
Design and synthesis of novel quinazolinone derivatives as anti-HBV agents with TLR8 agonist effect
European Journal of Medicinal Chemistry 2022.0
Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors
Journal of Medicinal Chemistry 2021.0
Design, Synthesis, and Structure–Activity Relationship of N-Aryl-N′-(thiophen-2-yl)thiourea Derivatives as Novel and Specific Human TLR1/2 Agonists for Potential Cancer Immunotherapy
Journal of Medicinal Chemistry 2021.0
Euodenine A: A Small-Molecule Agonist of Human TLR4
Journal of Medicinal Chemistry 2014.0
Discovery of benzimidazole substituted 1, 2, 4-oxadiazole compounds as novel anti-HBV agents with TLR8-agonistic activities
European Journal of Medicinal Chemistry 2022.0
Potent adjuvantic activity of a CCR1-agonistic bis-quinoline
Bioorganic & Medicinal Chemistry Letters 2012.0
Discovery and structure–activity relationship studies of quinolinone derivatives as potent IL-2 suppressive agents
Bioorganic & Medicinal Chemistry 2016.0